Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach

• Didik Setiawan ,

  * E-mail: d.didiksetiawan@gmail.com

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Faculty of Pharmacy, University of Muhammadiyah Purwokerto, Purwokerto, Indonesia

  ⨯
• Nikolaos Kotsopoulos,

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Global Market Access Solutions (GMAS), St-Prex, Switzerland

  ⨯
• Jan C. Wilschut,

  Affiliation Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯
• Maarten J. Postma,

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Institute of Science in Healthy Aging & healthcaRE (SHARE), University Medical Center Groningen (UMCG), Groningen, The Netherlands

  ⨯
• Mark P. Connolly

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Global Market Access Solutions (GMAS), St-Prex, Switzerland

  ⨯